Bristol-Myers Squibb (BMY) Tops Q3 EPS by 14c, Offers FY20 and FY21 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $59.12 -0.77%
EPS Growth %: +6.1%
Financial Fact:
Total Expenses: 3.36B
Today's EPS Names:
HOVR, VFS, PGR, More
EPS Growth %: +6.1%
Financial Fact:
Total Expenses: 3.36B
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.63, $0.14 better than the analyst estimate of $1.49. Revenue for the quarter came in at $10.5 billion versus the consensus estimate of $10.33 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2020 EPS of $6.25-$6.35, versus the consensus of $6.27.
Bristol-Myers Squibb sees FY2021 EPS of $7.15-$7.45, versus the consensus of $7.39.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- SpaceX's spectrum deal puts SIRI's satellite assets in focus
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
